Note to our followers: Our nearly 13-year run of daily publication of new content on came to a close at the end of 2018. Publisher Gary Schwitzer and other contributors may post new articles periodically. But all of the 6,000+ articles we have published contain lessons to help you improve your critical thinking about health care interventions. And those will be still be alive on the site for a couple of years.

Tags: ovarian cancer


Newsweek’s premature optimism about experimental ovarian cancer drug overlooks costs, harms and limitations of the evidence


Significant conflicts of interest not disclosed in LA Times story on modified Pap tests


Reuters turns unpublished pilot studies into news


PARP inhibitors: STAT’s look at new ovarian cancer drugs should have established why we need more on the market

1 6/15/2016

Thorough story on underuse of new ovarian cancer tests needed a few more numbers


Kids after cancer treatment? HealthDay breaks down evidence on ovarian transplant procedure


WSJ fills holes left by incomplete news release on beta-blockers and ovarian cancer

2 3/28/2015

Experts Back Angelina Jolie Pitt in Choices for Cancer Prevention


New treatment deep freezes ovarian tumors


Study: Vaccine for Breast, Ovarian Cancer Has Potential